Active, not recruitingPhase 2NCT05896124

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

Studying Primary biliary cholangitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Cascade Pharmaceuticals, Inc
Principal Investigator: Rong Deng
Cascade Pharmaceuticals, Inc
Intervention: 2mg CS0159(drug)
Enrollment: 75 target
Eligibility: 18-75 years · All sexes
Timeline: 2023 – 2026

Study locations (16)

The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei, Anhui, China
Beijing Friendship Hospital, Capitai Medical University, Beijing, Beijing Municipality, China
Beijing Youan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangzhou, China
Henan Provincial People's Hospital, Zhengzhou, Henan, China
Wuhan Union Hospital of China, Wuhan, Hubei, China
The Seconed Xiangya Hospital of Central South University, Changsha, Hunan, China
The Third People's Hospital of Zhenjiang, Zhenjiang, Jiangsu, China
The First Bethune Hospital of Jilin University, Changchun, Jilin, China
Qilu Hospital of Shandong University, Jinan, Shandong, China
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Shaoyifu Hospital of Zhejiang University Medical, Hangzhou, Zhejiang, China
+1 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05896124 on ClinicalTrials.gov

Other trials for Primary biliary cholangitis

Additional recruiting or active studies for the same condition.

See all trials for Primary biliary cholangitis →

← Back to all trials